Granted Patent
B2
US 12,433,959 · App. 17/281,014 · Granted Oct 7, 2025
Injectable hydrogels for controlled release of immunomodulatory compounds
Inventors:
Gillie A. Roth (Stanford, CA); Eric Andrew Appel (Stanford, CA); Mark Davis (Stanford, CA); Emily C. Gale (Stanford, CA); Santiago Correa (Stanford, CA)
A61K47/6937A61K9/06A61K39/015A61K39/145A61K39/21A61K39/39A61P31/16A61P35/00A61K2039/54A61K2039/55577A61K2039/55588A61K2039/6093
View Patent ↗
Loading inventors, assignments & file history…
Abstract
An immunomodulatory delivery system includes a hydrogel, a first immunomodulatory cargo encapsulated in the cargo, and a second immunomodulatory cargo encapsulated in the hydrogel. The hydrogel includes a polymer non-covalently crossed-linked with a plurality of nanoparticles. The first immunomodulatory cargo is smaller than the second immunomodulatory cargo. A ratio of a diffusivity of the first immunomodulatory cargo through the hydrogel to a diffusivity of the second immunomodulatory cargo through the hydrogel is less than 3.
Claims (37)
1. A method comprising:
administering a vaccine delivery system to a subject, wherein the vaccine delivery system comprises:
a hydrogel comprising a hydrophobically-modified cellulose derivative non-covalently cross-linked with a plurality of poly (ethylene glycol)-block-poly (lactic acid) (PEG-PLA) nanoparticles, wherein the hydrogel comprises about 1 wt % of the hydrophobically-modified cellulose derivative and about 5 wt % of the PEG-PLA nanoparticles;
a first immunomodulatory cargo encapsulated in the hydrogel, the first immunomodulatory cargo comprising an immune-activating compound; and
a second immunomodulatory cargo encapsulated in the hydrogel, the second immunomodulatory cargo comprising an antigen,
wherein when the vaccine delivery system is administered to the subject, the hydrogel forms a depot that is configured to (1) recruit antigen-presenting cells (APCs) to infiltrate into the depot, (2) activate the infiltrating APCs with the immune-activating compound and the antigen while the infiltrating APCs are present within the depot, and (3) allow the activated infiltrating APCs to migrate out of the depot.
2. The method of claim 1 , wherein the antigen comprises a protein.
3. The method of claim 1 , wherein the antigen comprises a subunit vaccine antigen.
4. The method of claim 1 , wherein the immune-activating compound comprises one or more of an adjuvant or a cytokine.
5. The method of claim 4 , wherein the immune-activating compound comprises the adjuvant and the adjuvant comprises a toll-like receptor agonist.
6. The method of claim 1 , wherein the hydrophobically-modified cellulose derivative is dodecyl-modified hydroxypropylmethylcellulose (HPMC-C 12 ).
7. The method of claim 1 , wherein the hydrogel is shear-thinning.
8. The method of claim 1 , wherein the first immunomodulatory cargo has a different molecular weight than the second immunomodulatory cargo.
9. The method of claim 8 , wherein a molecular weight of the first immunomodulatory cargo is at least 5 times greater than a molecular weight of the second immunomodulatory cargo, or wherein the molecular weight of the second immunomodulatory cargo is at least 5 times greater than the molecular weight of the first immunomodulatory cargo.
10. The method of claim 1 , wherein the first and second immunomodulatory cargos are released from the hydrogel at substantially the same rate after the vaccine delivery system is administered.
11. The method of claim 1 , wherein the antigen is an antigen for an infectious disease or cancer.
12. The method of claim 1 , wherein the vaccine delivery system is administered to the subject a single time.
13. The method of claim 1 , wherein the vaccine delivery system is administered to the subject via subcutaneous injection.
14. The method of claim 1 , wherein the hydrophobically-modified cellulose derivative is 5% to 30% modified with a hydrophobic moiety.
15. The method of claim 1 , wherein the hydrophobically-modified cellulose derivative is 10% to 15% modified with a dodecyl moiety.
16. The method of claim 1 , wherein the PEG-PLA nanoparticles have a diameter within a range from 30 nm to 50 nm.
17. The method of claim 1 , wherein a ratio of a diffusivity of the first immunomodulatory cargo through the hydrogel to a self-diffusivity of the hydrogel is less than 10.
18. The method of claim 1 , wherein a ratio of a diffusivity of the second immunomodulatory cargo through the hydrogel to a self-diffusivity of the hydrogel is less than 10.
19. A vaccine delivery system comprising:
a hydrogel comprising a hydrophobically-modified cellulose derivative non-covalently cross-linked with a plurality of poly (ethylene glycol)-block-poly (lactic acid) (PEG-PLA) nanoparticles, wherein the hydrogel comprises about 1 wt % of the hydrophobically-modified cellulose derivative and about 5 wt % of the PEG-PLA nanoparticles;
a first immunomodulatory cargo encapsulated in the hydrogel, the first immunomodulatory cargo comprising an immune-activating compound; and
a second immunomodulatory cargo encapsulated in the hydrogel, the second immunomodulatory cargo comprising an antigen,
wherein the hydrogel is configured to form a depot in a subject that (1) recruits antigen-presenting cells (APCs) to infiltrate into the depot, (2) activates the infiltrating APCs with the immune-activating compound and the antigen while the infiltrating APCs are present within the depot, and (3) allows the activated infiltrating APCs to migrate out of the depot.
20. The vaccine delivery system of claim 19 , wherein the antigen comprises a protein.
21. The vaccine delivery system of claim 19 , wherein the antigen comprises a subunit vaccine antigen.
22. The vaccine delivery system of claim 19 , wherein the immune-activating compound comprises one or more of an adjuvant or a cytokine.
23. The vaccine delivery system of claim 22 , wherein the immune-activating compound comprises the adjuvant and the adjuvant comprises a toll-like receptor agonist.
24. The vaccine delivery system of claim 19 , wherein the hydrophobically-modified cellulose derivative is dodecyl-modified hydroxypropylmethylcellulose (HPMC-C 12 ).
25. The vaccine delivery system of claim 19 , wherein the hydrogel is shear-thinning.
26. The vaccine delivery system of claim 19 , wherein the first immunomodulatory cargo has a different molecular weight than the second immunomodulatory cargo.
27. The vaccine delivery system of claim 26 , wherein a molecular weight of the first immunomodulatory cargo is at least 5 times greater than a molecular weight of the second immunomodulatory cargo, or wherein the molecular weight of the second immunomodulatory cargo is at least 5 times greater than the molecular weight of the first immunomodulatory cargo.
28. The vaccine delivery system of claim 19 , wherein the first and second immunomodulatory cargos are configured to be released from the hydrogel at substantially the same rate when the vaccine delivery system is administered.
Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 19, 2021
From: AGMON, GILLIE; APPEL, ERIC ANDREW; GALE, EMILY C.; CORREA, SANTIAGO
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 055964/0140 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 19, 2021
From: DAVIS, MARK
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 055964/0164 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 19, 2021
From: HOWARD HUGHES MEDICAL INSTITUTE
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 055964/0184 →
Continuity (2)
Provisional Application
62739587
· Oct 1, 2018
References Cited (178)
US 4192727A
· Ward
· 1980
[cited by applicant]
US 5143724A
· Leshchiner et al.
· 1992
[cited by applicant]
US 5410016A
· Hubbell et al.
· 1995
[cited by applicant]
US 5480436A
· Bakker et al.
· 1996
[cited by applicant]
US 5785993A
· Baker et al.
· 1998
[cited by applicant]
US 5888988A
· Elson
· 1999
[cited by applicant]
US 6150581A
· Jiang et al.
· 2000
[cited by applicant]
US 6673093B1
· Sawhney
· 2004
[cited by applicant]
US 6818018B1
· Sawhney
· 2004
[cited by applicant]
US 7125860B1
· Renier et al.
· 2006
[cited by applicant]
US 7347850B2
· Sawhney
· 2008
[cited by applicant]
US 8455001B2
· Ito et al.
· 2013
[cited by applicant]
US 8709450B2
· Kaneko et al.
· 2014
[cited by applicant]
US 8728524B2
· Bellini et al.
· 2014
[cited by applicant]
US 8748409B2
· Kaneko et al.
· 2014
[cited by applicant]
US 8778326B2
· Lu et al.
· 2014
[cited by applicant]
US 8859523B2
· Prestwich et al.
· 2014
[cited by applicant]
US 8916143B2
· Putnam et al.
· 2014
[cited by applicant]
US 9089730B2
· Shalev et al.
· 2015
[cited by applicant]
US 9289279B2
· Wilson et al.
· 2016
[cited by applicant]
US 20030180251A1
· Friedrich et al.
· 2003
[cited by applicant]
US 20040023842A1
· Pathak et al.
· 2004
[cited by applicant]
US 20050271727A1
· Yao
· 2005
[cited by applicant]
US 20060177481A1
· Sawhney
· 2006
[cited by applicant]
US 20070001156A1
· Toreki
· 2007
[cited by applicant]
US 20080069857A1
· Yeo et al.
· 2008
[cited by applicant]
US 20080107703A1
· Tabata et al.
· 2008
[cited by applicant]
US 20090294049A1
· Udipi et al.
· 2009
[cited by applicant]
US 20100291055A1
· Athanasiadis et al.
· 2010
[cited by applicant]
US 20110178184A1
· Kaneko et al.
· 2011
[cited by applicant]
US 20160030789A1
· Cordani
· 2016
[cited by applicant]
US 20160228601A1
· He et al.
· 2016
[cited by applicant]
US 20230398061A1
· Grosskopf
· 2023
[cited by examiner]
US 20240299532A1
· Appel
· 2024
[cited by examiner]
EP 2511336B1
· 2012
[cited by applicant]
KR 20060011503A
· 2006
[cited by applicant]
KR 20170110882A
· 2017
[cited by applicant]
WO WO93017669A1
· 1993
[cited by applicant]
WO WO03084481A2
· 2003
[cited by applicant]
WO WO2005110377A1
· 2005
[cited by applicant]
WO WO2013076305A1
· 2013
[cited by applicant]
WO WO2013124654A1
· 2013
[cited by applicant]
WO WO2014116187A1
· 2014
[cited by applicant]
WO WO2014125418A1
· 2014
[cited by applicant]
WO 2014039012A1
· 2015
[cited by applicant]
WO 2015066535A1
· 2015
[cited by applicant]
WO WO2015172073A1
· 2015
[cited by applicant]
WO WO2016049360A1
· 2016
[cited by applicant]
WO 2018078620A1
· 2018
[cited by applicant]
WO 2020072495A1
· 2020
[cited by applicant]
Goff, Peter H., et al. “Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.” Journal of Virology 89.6 (2015): 3221-3235.…
[cited by examiner]
Krammer, Florian, et al. “A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates.” (2012): e43603. (Year: 2012).
[cited by examiner]
CDC, Vaccines and the Diseases they Prevent, obtained online at: https://www.cdc.gov/vaccines/by-disease/index.html, downloaded on Feb. 12, 2025. (Year: 2024).
[cited by examiner]
Memorial Sloan Kettering Cancer Center, Cancer vaccines: The Types, How They Work, and Which Cancers They Treat, obtained online at: https://www.mskcc.org/cancer-care/diagnosis-treatment/cancer-treatments/immunotherapy/…
[cited by examiner]
Leukemia & Lymphoma Society, Vaccine Therapy, downloaded at https://www.lls.org/treatment/types-treatment/vaccine-therapy, downloaded on Feb. 12, 2025. (Year: 2025).
[cited by examiner]
Reid, The importance of Temperature and Viscosity, obtained online at: https://blog.rheosense.com/temperature-and-viscosity, downloaded on Feb. 12, 2025. (Year: 2021).
[cited by examiner]
Appel et al.; Activation energies control the macroscopic properties of physically cross-linked materials; Angew. Chem. Ind. Ed.; 53; 7 pgs.; Sep. 15, 2014.
[cited by applicant]
Appel et al.; Exploiting electrostatic interactions in polymer-nanoparticle hydrogels; ACS Macro letters; 4(8); pp. 848-852; Jul. 27, 2015.
[cited by applicant]
Appel et al.; Formation of single-chain polymer nanoparticles in water through host-guest interactions; Angew. Chem. Int. Ed.; 51; pp. 4185-4189; Apr. 23, 2012.
[cited by applicant]
Appel et al.; Gluing Gels: A nanoparticle solution; Nature Materials; 13(3); pp. 231-232; Mar. 2014.
[cited by applicant]
Appel et al.; High-water-content hydrogels from renewable resources through host-guest interactions; J. Am. Chem. Soc.; 134(28); pp. 11767-11773; Jul. 18, 2012.
[cited by applicant]
Appel et al.; Self-assembled hydrogels utilizing polymer-nanoparticle interactions; Nature Communications; 6; pp. 6295; doi: 10:1038/ncomms7295; 19 pages; (Author Manuscript); Feb. 19, 2015.
[cited by applicant]
Appel et al.; Supramolecular cross-linked metworks via host-guest complexation with cucurbit[8] uril; Journal of the American Chemical Society: 132(40); pp. 14251-14260; Sep. 16, 2010.
[cited by applicant]
Appel et al.; Supramolecular polymeric hydrogels; Chemical Society Reviews; 41(18); pp. 6195-6214; Sep. 2012.
[cited by applicant]
Appel et al.; Sustained release of proteins from high water content supramolecular polymer hydrogels; Biomaterials; 33(18); pp. 4646-4652; Jun. 1, 2012.
[cited by applicant]
Appel et al.; The control of cargo release from physically crosslinked hydrogels by crosslink dynamics; Biomaterials; 35(37); pp. 9897-9903; Dec. 1, 2014.
[cited by applicant]
Artivashist et al.; Hydrogels: Smart materials for drug delivery; Oriental Journal of Chemistry; 29(3); pp. 861-870; Nov. 5, 2013.
[cited by applicant]
Bang et al.; Injectable pullulan hydrogel for the prevention of postoperative tissue adhesion; International Journal of Biological Macromolecules; 87; pp. 155-162; Jun. 2016.
[cited by applicant]
Bao et al.; Swelling behaviors of organic/inorganic composites based on various cellulose derivatives and inorganic particles; Carbohydrate Polymers; 88(2); pp. 589-595; Apr. 2012.
[cited by applicant]
Bremer et al.; Laboratory scale clean-in-place (CIP) studies on the effectiveness of different caustic and acid wash steps on the removal of dairy biofilms; Intl. J. of Food Microb.; 106(3); pp. 254-262; Feb. 15, 2006.
[cited by applicant]
Bourges et al.; Synthesis and General Properties of Silated-Hydroxypropyl Methylcellulose in Prospect of Biomedical Use; Advances in Colloid and Interface Science; 99 (3), pp. 215-228; Dec. 2, 2002.
[cited by applicant]
Chen et al.; Injectable thermosensitive hydrogel containing hyaluronic acid and chitosan as barrier for prevention of postoperative peritoneal adhesion; Carbohydr. Polm.; 173; pp. 721-731; doi:10.1016/j.carbpol.2017.06.…
[cited by applicant]
Drevelle et al.; Thermal and fire behaviour of ammonium polyphosphate/acrylic coated cotton/PESFR fabric; Polymer Degradation and Stability; 88(1); pp. 130-137; Apr. 1, 2005.
[cited by applicant]
Ehrbar et al.; Drug-sensing hydrogels for the inducible release of biopharmaceuticals; Nature materials; 7(10); pp. 800-804; Oct. 2008.
[cited by applicant]
Evans et al.; Investigation into the transportation and melting of thick ice slurries in pipes; Intl. Journal of Refrig.; 31(1); pp. 145-151; Jan. 1, 2008.
[cited by applicant]
Fu et al.; Biodegradable and thermosensitive monomethoxy poly(ethylene glycol)-poly(lactic acid) hydrogel as a barrier for prevention of post-operative abdominal adhesion; journal of Biomedical Nanotechnology; 10(3); pp…
[cited by applicant]
Gesan-Guiziou et al.; Nanofiltration for the recovery of caustic cleaning-in-place solutions: robustness towards large variations of composition; Journal of Dairy Research; 69(4); pp. 633-643; Nov. 2002.
[cited by applicant]
Gimenez et al.; Long-term forest fire retardants: a review of quality, effectiveness, application and environmental considerations; Intl. J. of Wildland Fire; 13(1); pp. 1-15; Apr. 27, 2004.
[cited by applicant]
Grosskopf et al.; Injectable supramolecular polymer-nanoparticle hydrogels enhance human mesenchhymal stem cell delivery; Bioengineering & Translational Medicine, vol. 810147; pp. 1-11; Oct. 12, 2019.
[cited by applicant]
Gu et al.; Study on preparation and fire-retardant mechanism analysis of intumescent flame-retardant coatings; Surface and coatings tech.; 201(18); pp. 7835-7841; Jun. 25, 2007.
[cited by applicant]
Hales et al.; Ice fraction measurement of ice slurries through electromagnetic attenuation; Intl. J. of Refrig.; 47; pp. 98-104; Nov. 1, 2014.
[cited by applicant]
Harada et al.; Macroscopic self-assembly through molecular recognition; Nature Chem.; 3(1); pp. 34-37; Jan. 2011.
[cited by applicant]
Hoare et al.; Prevention of peritoneal adhesions using polymeric rheological blends; Acta Biomaterialia; 10(3); pp. 1187-1193; 16 pages; (Author Manuscript); Mar. 2014.
[cited by applicant]
Hu et al.; Detection of poly- and perfluoroalkyl substances (PFASs) in U.S. drinking water linked to industrial sites, military fire training areas, and wastewater treatment plants; Env. Sci. and Tech. Letters; 3(10); p…
[cited by applicant]
Ishiyama et al.; The prevention of peritendinous adhesions by phospholipid polymer hydrogel formed in situ by spontaneous intermolecular interactions; Biomaterials; 31(14); pp. 4009-4016; May 2010.
[cited by applicant]
Kapsabelis et al.; Adsorption of ethyl (hydroxyethyl) cellulose onto silica particles: the role of surface chemistry and temperature; J. of colloid and interface sci.; 228(2); pp. 297-305; Aug. 15, 2000.
[cited by applicant]
Karacam et al.; Prevention of pleural adhesions using a membrane containing polyethylene glycol in rats; International Journal of Medical Sciences; 8(5); pp. 380-386; (year of pub. sufficiently earlier than effective US…
[cited by applicant]
Krielen et al.; In-hospital costs of an admission for adhesive small bowel obstruction; World Journal of Emergency Surgery; 11(1); pp. 49; DOI 10.1186/s13017-016-0109-y; 8 pages; Dec. 2016.
[cited by applicant]
Krishna et al.; Protein- and oeptide-modified synthetic polymeric biomaterials; Peptide Science: Original Res. On Biomolecules; 94(1); pp. 32-48; Jan. 20, 2010.
[cited by applicant]
Lu et al.; Injectable shear-thinning hydrogels engineered with a self-assembled dock-and-lock mechanism; Biomaterials; 33(7); pp. 2145-2153; Mar. 2012.
[cited by applicant]
Maupin et al.; Estimated use of water in the United States in 2010; USGS Survey (No. 1405); 64 pgs.; (year of pub. sufficiently earlier than effective US filing date and any foreign priority date) 2014.
[cited by applicant]
Merin et al.; Cleaning-in-place in the dairy industry: criteria for reuse of caustic (NaOH) solutions, Le Lait; 82(3); pp. 357-366; May 1, 2002.
[cited by applicant]
Moody et al.; Monitoring perfluorinated surfactants in biota and surface water samples following an accidental release of fire-fighting foam into Etobicoke Creek; Environ. Sci. and Tech.; 36(4); pp. 545-551; Feb. 15, 20…
[cited by applicant]
Moody et al.; Occurrence and persistence of perfluorooctanesulfonate and other perfluorinated surfactants in groundwater at a fire-training area at Wurtsmith Air Force Base, Michigan, USA; J. Environ. Mon.; 5(2); pp. 34…
[cited by applicant]
Moody et al.; Perfluorinated surfactants and the environmental implications of their use in fire-fighting foams; Environ. Sci. and Technol.; 34(18); pp. 3864-3870; Sep. 15, 2000.
[cited by applicant]
Mulyasasmita et al.; Molecular-level engineering of protein physical hydrogels for predictive sol-gel phase behavior; Biomacromolecules; 12(10); pp. 3406-3411; Sep. 2, 2011.
[cited by applicant]
Nakahata et al.; Redox-responsive self-healing materials formed from host-guest polymers; Nature Comm.; 2(511); pp. 1-6; Oct. 25, 2011.
[cited by applicant]
Okabayashi et al; Adhesions after abdominal surgery: a systematic review of the incidence, distribution and severity; Surgery Today; 44(3); pp. 405-420; Mar. 1, 2014.
[cited by applicant]
Osada et al.; The effect of cross-linked hyaluronate hydrogel on the reduction of post-surgical adhesion reformation in rabbits; Journal of International Medical Research; 5; pp. 233-241; Sep. 1999.
[cited by applicant]
Parisi-Amon et al; Protein-engineered injectable hydrogel to improve retention of transplanted adipose-derived stem cells; Advanced Healthcare Materials: 2(3); pp. 428-432; 10 pages; (Author Manuscript); Mar. 2013.
[cited by applicant]
Park et al.; In situ supramolecular assembly and modular modification of hyaluronic acid hydrogels for 3D cellular engineering; ACS Nano; 6(4); pp. 2960-2968; Mar. 15, 2012.
[cited by applicant]
Patterson et al.; In situ characterization of the degradation of PLGA microspheres in hyaluronic acid hydrogels by optical coherence tomography; IEEE Transactions on Medical Imaging, vol. 28; pp. 74-81; Jan. 2009.
[cited by applicant]
Petka et al.; Reversible hydrogels from self-assembling artifical proteins; Science; 281(5375); pp. 389-392; Jul. 17, 1998.
[cited by applicant]
Pritchard et al.; An injectable thiol-acrylate poly(ethylene glycol) hydrogel for sustained release of methylprenisolone sodium succinate; Biomaterials; 32(2); pp. 587-597; 30 pages; (Author Manuscript); Jan. 2011.
[cited by applicant]
Quarini; Ice-pigging to reduce and remove fouling and to achieve clean-in-place; Applied thermal Eng.: 22(7); pp. 747-753; May 1, 2002.
[cited by applicant]
Quarini et al.; Investigation and development of an innovative pigging technique for the water-supply industry; Proc. Inst. Mech. Eng., Part E: J. Proc. Mech. Eng.; 224(2); pp. 79-89; May 1, 2010.
[cited by applicant]
Rodell et al.; Rational design of network properties in guest-host assembled and shear-thinning hyaluronic acid hydrogels; Biomacromolecules; 14(11); pp. 4125-4134; 20 pages; (Author Manuscript); Oct. 14, 2013.
[cited by applicant]
Rodell et al.; Shear-thinning supramolecular hydrogels with secondary autonomous covalent crosslinking to modulate viscoelastic properties in vivo; Adv. Functional Mat.; 25(4); pp. 636-644; Jan. 28, 2015.
[cited by applicant]
Rose et al.; Nanoparticle solutions as adhesives for gels and biological tissues; Nature; 505(7483); pp. 382-385; Jan. 16, 2014.
[cited by applicant]
Rowland et al.; Dynamically crosslinked materials via recognition of amino acids by cucurbit [8] uril; J. Mat. Chem. B; 1(23); pp. 2904-2910; Apr. 30, 2013.
[cited by applicant]
Salem et al.; Porous polymer and cell composites that self-assemble in situ, Advanced Materials; 15(3); pp. 210-213; Feb. 5, 2003.
[cited by applicant]
Schroeder; Can fire suppressant geis protect log decks. A case study to test the concept; Wildland Fire Operations Research Group; Vancouver; (year of pub. sufficiently earlier than effective US filing date and any fore…
[cited by applicant]
Schroeder; Can fire suppressant gels protect log decks? Part III—Two case studies to test gel effectiveness against radiant and convective heat transfer; Vancouver; (year of pub. sufficiently earlier than effective US f…
[cited by applicant]
Schroeder; Effectiveness of forest fuel management: a crown fire case study in the Northwest Territories, Canada; Forest Eng. Res. Inst. of Canada, Vancouver; (year of pub. sufficiently earlier than effective US filing …
[cited by applicant]
Shen et al.; Tuning the erosion rate of artifical protein hydrogels through control of network topology; Nature Materials; 5(2); pp. 153-158; Feb. 2006.
[cited by applicant]
Shi et al.; Polymeric hydrogels for post-operative adhesion prevention: a review; Materials Express; 7(6); pp. 417-438; Dec. 2017.
[cited by applicant]
Song et al.; Peritoneal adhesion prevention with a biogradable and injectable N, O-carboxymethyl chitosan-aldehyde hyaluronic acid hydrogel in a rat repeated injury model; Scientific Reports; 6; doi: 10.1038/srep37600; …
[cited by applicant]
Stapleton et al.; A novel, shear-assembling shear-thinning polymer-nanoparticle hydrogel diminishes post-operative thoracic adhesion in a podent model of ischemic cardiomyopathy; Circulation; 136(1); Abstract 21311; 6 p…
[cited by applicant]
Tamesue et al.; Linear versus dendritic molecular binders for hydrogel network formation with clay nanosheets: studies with ABA triblock copolyethers carrying guanidinium ion pendants; J. Am. Chem. Soc.; 135 (41); pp. 1…
[cited by applicant]
Wang et al.; High-water-content mouldable hydrogels by mixing clay and a dendritic molecular binder; Natue 463(7279); pp. 339-343; Jan. 21, 2010.
[cited by applicant]
Wang et al.; PLGA-chitosan/PLGA-alginate nanoparticle blends as biodegradable colloidal gels for seeding human umbilical cord mesenchymal stem cells; Journal of Bionedical Research, Part A; 96(3); pp. 520-527; (Author M…
[cited by applicant]
Webber et al.; Supramolecular biomaterials; Nature Materials; 15(1); pp. 13-26; Jan. 2016.
[cited by applicant]
Wong Po Foo et al.; Two-component protein-engineered physical hydrogels for cell encapsulation; Proceedings of the National Academy of Sciences; 106(52); pp. 22067-22072; doi: 10.1073/pnas.0904851106; 6 pages; Dec. 29, …
[cited by applicant]
Yamaguchi et al.; Photoswitchable gel assembly based on molecular recognition; Nature Comm.; 3(603); pp. 1-5; Jan. 3, 2012.
[cited by applicant]
Yamaguchi et al.; Self-assembly of gels through molecular recognition of cyclodextrins: Shape selectivity for linear and cyclic guest molecules; Macromolecules; 44(8); pp. 2395-2399; Mar. 25, 2011.
[cited by applicant]
Yang et al.; A postoperative anti-adhesion barrier based on photoinduced imine-crosslinking hydrogel with tissue-adhesive ability; Acta Biomaterialia; 62; pp. 199-209; Oct. 15, 2017.
[cited by applicant]
Yeo et al.; Polymers in the prevention of peritoneal adhesions; European Journal of Pharaceutics and Biopharmaceutics; 68(1); pp. 57-66; 16 pages; (Author Manuscript); Jan. 2008.
[cited by applicant]
Yu et al.; Comparative studies of thermogels in preventing post-operative adhesions and corresponding mechanisms; Biomater. Sci.; 2(8); pp. 1100-1109; doi: 10.1039/C4M00029C; retrived from the internet (http://pubs.rso.…
[cited by applicant]
Zhang et al.; Biodegradable and thermoreversible PCLA-PEG-PCLA hydrogel as a barrier for prevention of post-operative adhesion; Biomaterials; 32(21); pp. 4725-4736; Jul. 2011.
[cited by applicant]
Zhu et al.; Metal and light free “click” hydrogels for prevention of post-operative peritoneal adhesions; Polymer Chemistry; 5(6); pp. 2018-2026; (year of pub. sufficiently earlier than effective US filing date and any …
[cited by applicant]
Xu et al.; Genetically engineered block copolymers: influence of the length and structure of the coiled-coil blocks on hydrogel self-assembly; Pharm. Res.; 25(3); pp. 674-682; Mar. 1, 2008.
[cited by applicant]
Xu et al.; Reversible hydrogels from self-assembling genetically engineered protein block copolymers; Biomacromolecules; 6(3); pp. 1739-1749; May 9, 2005.
[cited by applicant]
Fan et al.; Injectable hydrogels for localized cancer therapy; Frontiers in Chemistry; vol. 7;Article 675; doi: 10.3389/fchem.2019.00675; 1 1 pages; Oct. 2019.
[cited by applicant]
Richards; Cancer immunotherapy gets assist from micro-scale engineering; 7 pages; retrieved from the internet (https://www.fredhutch.org/en/news/center-news/2019/12/stephan-thin-film-stent-immunotherapy.html) on Nov. 11…
[cited by applicant]
Adusumilli et al.; Regional delivery of mesothelin-targeted car t cell therapy generates potent and long lasting cd4-dependent tumor immunity; Science Translational Medicine; 6(261); pp. 261ra151-261ra151; 31 pages; (Au…
[cited by applicant]
Anthony et al.; Scalable manufacturing of biomimetic moldable hydrogels for industrial applications; Porceedings National Academy Sciences; 113(50); pp. 14255-14260; Dec. 2016.
[cited by applicant]
Cheung et al; Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary t cells; Nature Biotechnology; 36(2); 160-169; 29 pages; (Author Manuscript); Feb. 2018.
[cited by applicant]
Chu et al.; A bright cyan-excitable orange fluorescent protein facilitates dual-emission microscopy and enhances bioluminescence imaging in vivo; Nature Biotechnology; 34(7); pp. 760-767; 29 pages; (Author Manuscript); …
[cited by applicant]
Conlon et al.; Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trail of recombinant human interleukin-15 in patients with ca…
[cited by applicant]
Duhen et al.; Co-expression of cd39 and cd103 identifies tumor-reactive cd8 t cells in human solid tumors; Nature Communications; 9(1); pp. 1-13; Jul. 2018.
[cited by applicant]
Foster et al.; The diverse roles of hydrogel mechanics in injectable stem cell transplantation; Current Opinion Chemical Engineering: 15; pp. 15-23; 17 pages; (Author Manuscript); Feb. 2017.
[cited by applicant]
Graham et al.; Allogeneic car-t cells: more than ease of access ?; Cell; 7 (10); pp. 155; doi: 10.3390/cells7100155; 11 pages; Oct. 2018.
[cited by applicant]
Hall et al.; Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate; ACS Chemical Bilogy; 7(11); pp. 1848-1857; Nov. 2012.
[cited by applicant]
Hughes et al.; Transfer of a tor gene derived from a patient with marked antitumor response conveys highly active t-cell effector functions; Human Gene Therapy; 16(4): pp. 457-472; 25 pages; (Author Manuscript); Apr. 20…
[cited by applicant]
Labanieh et al.; Programming car-t-cells to kill cancer; Nature Biomedical Engineering; 2(6); pp. 377-391; (year of pub. sufficiently earlier than effective US filing date and any foreign priority date) 2018.
[cited by applicant]
Long et al.; 4-1BB costimulation ameliorates t cell exhaustion induced by tonic signaling of chimeric antigen receptors; Nature Medicine; 21(6); pp. 581-590; 27 pages; (Auhtor Manuscript); Jun. 2015.
[cited by applicant]
Lotze et al.; Clinical effects and toxicity of interleukin-2 in patients with cancer; Cancer; 58(12); pp. 2764-2772; Dec. 1986.
[cited by applicant]
Majzner et al.; Car t cells targeting b7-h3, a pan-cancer antigen, demonstrate potent preclinical activity against pediatric solid tumors and brain tumors; Clinical Cancer Research; 25(8); pp. 2560-2574; Apr. 2019.
[cited by applicant]
Miller et al.; A first-in-human phase 1 study of subcutaneous outpatient human 1L15 (rhIL15) in adult with advanced solid tumors; Clinical Cancer Research; 24(7); pp. 1525-1535; Apr. 2018.
[cited by applicant]
Nair et al.; A simple practice guide for dose conversion between animals and human; Journal Basic Clinical Pharmacy; 7(2); pp. 27-31; Mar. 2016.
[cited by applicant]
Ring et al.; Mechanistic and structural insight into the functional dichotomy between il-2 and il-15; Nature Immunology; 13(12); pp. 1187-1195; 26 pages; (Author Manuscript); Dec. 2012.
[cited by applicant]
Shaner et al.; A bright monomeric green fluorescent protein derived from branchiostoma lanceolatum; Nature Methods; 10(5); pp. 407-409; 18 pages; (Author Manuscript); May 2013.
[cited by applicant]
Smith et al.; Biopolymers codelivering engineered t cells and sting agonists can eliminate heterogeneous tumors; The Journal clinical Investigation; 127(6); pp. 2176-2191; Jun. 2017.
[cited by applicant]
Sridhar et al.; Regional delivery of chimeric antigen receptor (car) t-cells for cancer therapy; Cancers; 9(7); pp. 92; 10 pages; doi:10.3390/cancers9070092; Jul. 2017.
[cited by applicant]
Stapleton et al.; Use of a supramolecular polymeric hydrogel as an effective post-operative pericardial adhesion barrier; Nature Biomedical Engineering; 3(8); pp. 611-620; Aug. 2019.
[cited by applicant]
Stephan et al.; Bipolymer implants enhance the efficacy of adoptive t-cell therapy; Nature Biotechnology; 33(1); pp. 97-101; 18 pages; (Author Manuscript); Jan. 2015.
[cited by applicant]
Titov et al.; The biological basis and clinical symptoms of car-t therapy associated toxicites; Cell Death andd Disease; 9(9); pp. 1-15; Sep. 2018.
[cited by applicant]
Waldmann et al.; Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human il-15 in rhesus macaques; Blood; The Journal American Society Hermatology; 11…
[cited by applicant]
Walker et al.; Tumor antigen and receptor densities regulate efficacy of a chimeric antigen receptor targeting anaplastic lymphoma kinase; Molecular Therapy; 25(9); pp. 2189-2201; Sep. 2017.
[cited by applicant]
Ou et al., “Broad and Durable Humoral Responses Following Single Hydrogel Immunization of SARS-CoV-2 Subunit Vaccine,” Adv. Healthcare Matter 2023, 2301495, pp. 1-14.
[cited by applicant]
European Patent Application No. 19869113.1, Extended European Search Report, Jun. 9, 2022, 7 pages.
[cited by applicant]
International Patent Application No. PCT/US2019/054070, International Preliminary Report on Patentability, Mar. 23, 2021, 8 pages.
[cited by applicant]
International Patent Application No. PCT/US2019/054070, International Search Report and Written Opinion of the International Searching Authority, Dec. 30, 2019, 11 pages.
[cited by applicant]